- Home
- HMY vs HALO Comparison
HMY vs HALO Comparison
Compare HMY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMY | HALO |
|---|---|---|
| Founded | 1950 | 1998 |
| Country | South Africa | United States |
| Employees | 34350 | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 8.8B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | HMY | HALO |
|---|---|---|
| Price | $14.18 | $61.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $16.00 | ★ $78.18 |
| AVG Volume (30 Days) | ★ 4.5M | 1.3M |
| Earning Date | 02-04-2016 | 05-05-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.56 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | $40.34 | $28.24 |
| Revenue Next Year | $22.08 | $12.79 |
| P/E Ratio | ★ $15.60 | $24.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.57 | $47.50 |
| 52 Week High | $26.04 | $82.22 |
Technical Indicators
Market Signals| Indicator | HMY | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 30.59 |
| Support Level | $13.53 | $61.23 |
| Resistance Level | $15.65 | $65.40 |
| Average True Range (ATR) | 0.64 | 1.54 |
| MACD | -0.11 | -0.06 |
| Stochastic Oscillator | 18.68 | 1.27 |
Price Performance
Historical ComparisonAbout HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.